DAY 1 / ‏‏‎ ‎

07:30 AM - 08:30 AM
08:30 AM - 09:00 AM
Plenary View Session
Description

Chairman’s Opening Remarks

Smart Pharma: Key Trends that are Transforming Drug Discovery and Development

This opening session will set the stage for the discussions that will take place over the course of the Summit and identify the key trends that are taking hold in biopharma and reshaping drug discovery and clinical development. Themes will include:

  • Reduced timelines and improved accuracy of prediction of safety and efficacy
  • Diversified drug pipelines with new targets and drug re-purposing
  • Challenges: data sharing, access to reliable, robust data, and establishing new standardization
  • The dynamics of the continually evolving partnership ecosystem – biopharma, technology platforms, CROs, investors, regulatory and patients.
Chair
Harry Glorikian, General Partner, New Ventures Funds
Author: MoneyBall Medicine: Thriving in the New Data-Driven Healthcare Market
09:00 AM - 09:40 AM
Plenary View Session
Description

Executive Viewpoints Debate: What Will it Take to Make the Use of AI/ML Tools Scalable?

  • How do you translate AI/ML technology into patient impact
    • Better treatments
    • Higher quality outcomes
    • Less adverse effect
  • Streamlining processes enterprise-wide
Speaker
Dimitris K. Agrafiotis, PhD, Chief Information Officer, Novartis Institutes for BioMedical Research (NIBR)
Speaker
Niven R. Narain, Ph.D, Co-Founder, President & CEO, BERG
Speaker
Andrew Radin, CEO & Co-Founder, twoXAR Pharmaceuticals
09:40 AM - 09:55 AM
09:55 AM - 10:10 AM
Plenary View Session
Description

Using AI to Generate Patient Data: How Digital Twins are Shaping Clinical Trials

Digital twins are AI-generated placebo patient data perfectly matched to actual trial patients. With a universal goal of being able to run better and faster clinical trials, this session will use an Alzheimer’s use case to demonstrate how digital twins can ultimately  result in increased confidence in trial results.

Speaker
Charles Fisher, Ph.D, Founder and CEO, Unlearn.AI
10:10 AM - 10:40 AM
10:40 AM - 11:05 AM
Plenary

Data Management & Data Curation: Making Data Fit for Research

Speaker
Mimi Huizinga, MD, MPH, VP and Head, US Oncology Medical, Novartis Oncology
Speaker
Meghan Raman, Head, R&D Data Lake and Analytics, Bristol-Myers Squibb
11:05 AM - 11:30 AM
Plenary View Session
Description

Data Ownership/Life Data Economics

Use Case: Fission & Fusion: The Critical Mass Moment for Biopharma and Data

Speaker
Brian S. Martin, Head of AI R&D Information Research, AbbVie
11:30 AM - 11:55 AM
Plenary

Panel Discussion: The Use of AI in Predicting and Preventing Pandemics

Moderator
Annastasiah Mudiwa Mhaka, Ph.D, Co-Founder and Convenor, Alliance for AI in Healthcare (AAIH)
11:55 AM - 12:20 PM
Plenary View Session
Description

The need for a modernized drug development model in a pandemic leveraging RWE and advanced analytics

Use Case: The need for a modernized drug development model in a pandemic leveraging RWE and advanced analytics

  • The myth of the value of randomized controlled trials in a pandemic
  • How the traditional drug development model leaves patients behind
  • Modernizing drug development with an integrated RWE research platform and advanced analytics
  • Barriers to overcome with government and regulators
Speaker
Ülo Palm, MD, Ph.D, Senior Vice President, Head of Digital Sciences, Allergan
12:20 PM - 1:20 PM
1:20 PM - 1:20 PM
Research & Discovery

Track Chair

Chair
Brian S. Martin, Head of AI R&D Information Research, AbbVie
Clinical Development

Track Chair

Strategy & Leadership

Track Chair

Chair
Annastasiah Mudiwa Mhaka, Ph.D, Co-Founder and Convenor, Alliance for AI in Healthcare (AAIH)
1:20 PM - 1:45 PM
Research & Discovery View Session
Description

Molecule Generation

Use Case: Using AI to Deconvolute and Take Away the Complexity of Biology: Developing the Next Generation of Precision Oncology Therapeutics to Strike and Beat Cancer

Transformative treatment advances in oncology require a greater understanding of cancer as a complex disease and matching treatment to patient tumor biology. This use case will cover an example of a platform that leverages systems biology and pharmacology-based AI to develop a new wave of therapeutics and inform the rational design of combination trials matched to the right patient population.

Speaker
Laurent Audoly, Ph.D, CEO, Founder, Parthenon Therapeutics
Clinical Development

Patient Recruitment

1:50 PM - 2:05 PM
Research & Discovery

Validation

Clinical Development

Patient Adherence and Retention

2:05 PM - 2:35 PM
2:35 PM - 3:15 PM
Plenary

Deep Dive Sessions

Deep Dive sessions provide the “big value in small group discussions” that is necessary in times of industry transformation. Each session will be led by an industry expert who will kick off the conversation with a brief case study example. This will be followed by a group brainstorming discussion of ideas and options around how best to achieve specific outcomes and overcome constraints focused on specific use cases.

Clinical Development

DEEP DIVE: Clinical Development

Strategy & Leadership

DEEP DIVE: Privacy

Speaker
Anna Langhorne, Ph.D, Esq, Global Data Privacy Counsel, Regeneron Pharmaceuticals, Inc.
3:20 PM - 3:45 PM
Research & Discovery

Synthesis

Clinical Development

Virtual/Hybrid Trials

Strategy & Leadership

Culture/Talent Management

3:50 PM - 4:20 PM
Plenary View Session
Description

Leader Perspectives: Achieving Consistency in Validating & Operationalizing the AI / ML Automation Efforts Transforming Biopharma

This session will feature a panel of leaders discussing emerging forces that are shaping the global future of biopharma, and how intelligent automation and AI is transforming how we work. The session will include discussions on the current technology landscape in biopharma, particularly in pharmacovigilance; intelligent automation opportunities in PV; and propose consideration for validating intelligent automation technologies in PV to promote inspection readiness and inform third-party development.

Speaker
Janice Chang, Executive Vice President, TransCelerate BioPharma, Inc.
4:25 PM - 5:00 PM
Plenary View Session
Description

Spotlight Presentations (max 6)

Each speaker presents a concise and fast-paced 5-minute presentation that will introduce you to an innovative way of solving a problem, a new technology or tool, or a transformative approach to solving common issues facing biopharma companies today. Immediately following the spotlight presentations, attendees can meet with these innovative companies in a relaxed atmosphere during the evening reception.

Speaker
Aaron Aude, M.S., M.B., National Director, Enterprise Collaboration, Centric Consulting
Speaker
Ariel Katz, Co-Founder, H1
Speaker
Good Machine Learning Practices and Predictive Biomarkers in Clinical Development
5:00 PM - 6:00 PM
6:00 PM - 8:00 PM